The primary objective of this study is to evaluate several interventions given to participants with severe asthma. Interventions are administered in a crossover manner with 16-week treatment periods followed by 8 to 16-week washout. Treatment sequence will be randomly assigned as either test treatment followed by matching placebo or vice-versa.